Pfizer (PFE) Tops Q2 EPS by 14c; raises guidance
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $28.30 +3.85%
Financial Fact:
Less: Net income attributable to noncontrolling interests: 0
Today's EPS Names:
ZTO, AMMX, AFIB, More
Financial Fact:
Less: Net income attributable to noncontrolling interests: 0
Today's EPS Names:
ZTO, AMMX, AFIB, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q2 EPS of $0.60, $0.14 better than the analyst estimate of $0.46. Revenue for the quarter came in at $13.3 billion versus the consensus estimate of $13.03 billion.
GUIDANCE:
Pfizer sees FY2024 EPS of $2.45-$2.65, versus the consensus of $2.38. Pfizer now sees FY2024 revenue of $59.5-62.5 billion, versus the consensus of $60.7 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FOMC minutes from July 28-29th meeting
- Marti Technologies (MRT) Misses Q2 EPS by 9c ; Offers Guidance
- Novavax (NVAX) 11K contracts of August 28 weekly 9 calls trade, share price up 8.8%
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
